These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
469 related articles for article (PubMed ID: 17316406)
1. Refractory epilepsy: clinical overview. French JA Epilepsia; 2007; 48 Suppl 1():3-7. PubMed ID: 17316406 [TBL] [Abstract][Full Text] [Related]
2. The potential of pharmacogenetics in the treatment of epilepsy. Depondt C Eur J Paediatr Neurol; 2006 Mar; 10(2):57-65. PubMed ID: 16531088 [TBL] [Abstract][Full Text] [Related]
3. Quantifying the response to antiepileptic drugs: effect of past treatment history. Schiller Y; Najjar Y Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707 [TBL] [Abstract][Full Text] [Related]
4. Plasticity of antiepileptic drug targets. Beck H Epilepsia; 2007; 48 Suppl 1():14-8. PubMed ID: 17316408 [TBL] [Abstract][Full Text] [Related]
5. Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms. Schmidt D; Löscher W Epilepsia; 2005 Jun; 46(6):858-77. PubMed ID: 15946327 [TBL] [Abstract][Full Text] [Related]
6. Refractory epilepsy: a clinically oriented review. Beleza P Eur Neurol; 2009; 62(2):65-71. PubMed ID: 19521080 [TBL] [Abstract][Full Text] [Related]
7. The relationship between the pharmacology of antiepileptic drugs and human gene variation: an overview. Ferraro TN; Buono RJ Epilepsy Behav; 2005 Aug; 7(1):18-36. PubMed ID: 15979945 [TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic, pharmacodynamic, and pharmacogenetic targeted therapy of antiepileptic drugs. Anderson GD Ther Drug Monit; 2008 Apr; 30(2):173-80. PubMed ID: 18367977 [TBL] [Abstract][Full Text] [Related]
9. Likelihood of seizure remission in an adult population with refractory epilepsy. Callaghan BC; Anand K; Hesdorffer D; Hauser WA; French JA Ann Neurol; 2007 Oct; 62(4):382-9. PubMed ID: 17880009 [TBL] [Abstract][Full Text] [Related]
10. Response to antiepileptic drug therapy: winners and losers. Brodie MJ Epilepsia; 2005; 46 Suppl 10():31-2. PubMed ID: 16359468 [TBL] [Abstract][Full Text] [Related]
11. Can drug resistance in epilepsy be minimized? Challenging commonly held beliefs. Perucca E Epileptic Disord; 2005 Sep; 7 Suppl 1():S14-21. PubMed ID: 16120489 [TBL] [Abstract][Full Text] [Related]
12. Considerations in the choice of an antiepileptic drug in the treatment of epilepsy. Azar NJ; Abou-Khalil BW Semin Neurol; 2008 Jul; 28(3):305-16. PubMed ID: 18777477 [TBL] [Abstract][Full Text] [Related]
13. Therapeutic strategies in the choice of antiepileptic drugs. de Borchgrave V; Delvaux V; de Tourchaninoff M; Dubru JM; Ghariani S; Grisar T; Legros B; Ossemann M; Sadzot B; Tugendhaft P; Van Bogaert P; van Rijckevorsel K; Acta Neurol Belg; 2002 Mar; 102(1):6-10. PubMed ID: 12094563 [TBL] [Abstract][Full Text] [Related]
14. Outcomes in elderly patients with newly diagnosed and treated epilepsy. Brodie MJ; Stephen LJ Int Rev Neurobiol; 2007; 81():253-63. PubMed ID: 17433929 [TBL] [Abstract][Full Text] [Related]
15. [Drug-resistant epilepsy]. Nakken KO; Taubøll E Tidsskr Nor Laegeforen; 2009 Oct; 129(19):1986-9. PubMed ID: 19823202 [TBL] [Abstract][Full Text] [Related]
16. Results of treatment changes in patients with apparently drug-resistant chronic epilepsy. Luciano AL; Shorvon SD Ann Neurol; 2007 Oct; 62(4):375-81. PubMed ID: 17253624 [TBL] [Abstract][Full Text] [Related]
17. Drug treatment of epilepsy: options and limitations. Schmidt D Epilepsy Behav; 2009 May; 15(1):56-65. PubMed ID: 19236951 [TBL] [Abstract][Full Text] [Related]